Anticancer Activity and Molecular Targets of Piper cernuum Substances in Oral Squamous Cell Carcinoma Models

Oral squamous cell carcinoma (OSCC) is a worldwide public health problem, with high morbidity and mortality rates. The development of new drugs to treat OSCC is paramount. Piper plant species have shown many biological activities. In the present study, we show that dichloromethane partition of Piper cernuum (PCLd) is nontoxic in chronic treatment in mice, reduces the amount of atypia in tongues of chemically induced OSCC, and significantly increases animal survival. To identify the main active compounds, chromatographic purification of PCLd was performed, where fractions 09.07 and 14.05 were the most active and selective. These fractions promoted cell death by apoptosis characterized by phosphatidyl serine exposition, DNA fragmentation, and activation of effector caspase-3/7 and were nonhemolytic. LC–DAD–MS/MS analysis did not propose matching spectra for the 09.07 fraction, suggesting compounds not yet known. However, aporphine alkaloids were annotated in fraction 14.05, which are being described for the first time in P. cernuum and corroborate the observed cytotoxic activity. Putative molecular targets were determined for these alkaloids, in silico, where the androgen receptor (AR), CHK1, CK2, DYRK1A, EHMT2, LXRβ, and VEGFR2 were the most relevant. The results obtained from P. cernuum fractions point to promising compounds as new preclinical anticancer candidates.

[1]  T. Umehara,et al.  A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression , 2023, Nature Communications.

[2]  B. K. Robbs,et al.  Chemoselective Synthesis of Mannich Adducts from 1,4-Naphthoquinones and Profile as Autophagic Inducers in Oral Squamous Cell Carcinoma , 2022, Molecules.

[3]  B. K. Robbs,et al.  Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma , 2022, Molecules.

[4]  Qiurong Sun,et al.  Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway , 2022, Bioengineered.

[5]  Huan Liu,et al.  EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression , 2021, Cell & Bioscience.

[6]  N. Park,et al.  DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma. , 2021, Experimental cell research.

[7]  I. Mushtaq,et al.  Targeting EHMT2/ G9a for cancer therapy: progress and perspective. , 2020, European journal of pharmacology.

[8]  B. K. Robbs,et al.  Cytotoxic effect of pure compounds from Piper rivinoides Kunth against oral squamous cell carcinoma , 2020, Natural product research.

[9]  R. Mosa,et al.  Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases , 2020, Drug design, development and therapy.

[10]  Kai-Ping Chang,et al.  Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts , 2020, Cancers.

[11]  R. Chen,et al.  Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 , 2020, Cell Death and Disease.

[12]  J. Zeng,et al.  Investigation of fragmentation behaviours of isoquinoline alkaloids by mass spectrometry combined with computational chemistry , 2020, Scientific Reports.

[13]  Cheng Wang,et al.  LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial–Mesenchymal Transition , 2019, Front. Oncol..

[14]  G. Giuliana,et al.  Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives , 2019, Front. Physiol..

[15]  H. Adeola,et al.  Concordance between clinical and histopathologic diagnosis and an audit of oral histopathology service at a Nigerian tertiary hospital , 2019, The Pan African medical journal.

[16]  N. Abdul Majid,et al.  Investigation of Boldine as a Potential Telomerase Inhibitor by Downregulation of hTERT/hTERC in HCT 116 Human Colon Carcinoma Cells , 2019, Sains Malaysiana.

[17]  Xiaomin Liao,et al.  Androgen receptor promotes oral squamous cell carcinoma cell migration by increasing EGFR phosphorylation , 2019, OncoTargets and therapy.

[18]  Steffen Lindert,et al.  Improving inverse docking target identification with Z‐score selection , 2019, Chemical biology & drug design.

[19]  A. Siger,et al.  Column chromatography as a method for minor components removal from rapeseed oil , 2019, Grasas y Aceites.

[20]  B. Salehi,et al.  Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications , 2019, Molecules.

[21]  R. Battistutta,et al.  Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility. , 2019, Journal of natural products.

[22]  Adel M. Al-ghazzawi.  Anti-cancer activity of new benzyl isoquinoline alkaloid from Saudi plant Annona squamosa , 2019, BMC Chemistry.

[23]  B. K. Robbs,et al.  Cytotoxicity and selectiveness of Brazilian Piper species towards oral carcinoma cells. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  P. Thomson,et al.  Perspectives on oral squamous cell carcinoma prevention—proliferation, position, progression and prediction , 2018, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[25]  A. Barison,et al.  ALKALOIDS FROM LEAVES OF GUATTERIA POGONOPUS (ANNONACEAE) AND THEIR CYTOTOXICITIES , 2018 .

[26]  Cristian Suárez-Rozas,et al.  Telomerase Inhibition by a New Synthetic Derivative of the Aporphine Alkaloid Boldine , 2018, International journal of molecular sciences.

[27]  Yin Han,et al.  Design, synthesis, and anticancer properties of isocorydine derivatives. , 2017, Bioorganic & medicinal chemistry.

[28]  R. Pedrosa,et al.  Antitumor activity of conventional and supercritical extracts from Piper nigrum L. cultivar Bragantina through cell cycle arrest and apoptosis induction , 2017 .

[29]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[30]  Jinjun Li,et al.  Derivate Isocorydine (d-ICD) Suppresses Migration and Invasion of Hepatocellular Carcinoma Cell by Downregulating ITGA1 Expression , 2017, International journal of molecular sciences.

[31]  B. Cassels,et al.  PHYTOCHEMICAL ANALYSIS OF ALKALOIDS FROM THE CHILEAN ENDEMIC TREE CRYPTOCARYA ALBA , 2016 .

[32]  Kristian Fog Nielsen,et al.  Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking , 2016, Nature Biotechnology.

[33]  Karuna A. Rawat,et al.  Synthesis of fluorescent nitrogen-doped carbon dots from dried shrimps for cell imaging and boldine drug delivery system , 2016 .

[34]  L. Travassos,et al.  Camphene isolated from essential oil of Piper cernuum (Piperaceae) induces intrinsic apoptosis in melanoma cells and displays antitumor activity in vivo. , 2015, Biochemical and biophysical research communications.

[35]  T. Sugino,et al.  Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression , 2015, Oncotarget.

[36]  César Rivera,et al.  Essentials of oral cancer. , 2015, International journal of clinical and experimental pathology.

[37]  A. Barison,et al.  CHEMICAL CONSTITUENTS FROM THE STEM BARK OF Annona pickelii (Annonaceae) , 2015 .

[38]  Sakineh Kazemi Noureini,et al.  Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations. , 2015, Chemico-biological interactions.

[39]  R. Agarwal,et al.  Grape seed extract and resveratrol prevent 4‐nitroquinoline 1‐oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses , 2015, Molecular carcinogenesis.

[40]  L. Meijer,et al.  10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A , 2015, Journal of medicinal chemistry.

[41]  Wai-Nam Liu,et al.  Apoptosis- and differentiation-inducing activities of jacaric acid, a conjugated linolenic acid isomer, on human eosinophilic leukemia EoL-1 cells. , 2014, Oncology reports.

[42]  W. Wong,et al.  Evaluation of cytotoxic and chemotherapeutic properties of boldine in breast cancer using in vitro and in vivo models , 2014, Drug design, development and therapy.

[43]  G. Pizzo,et al.  Diagnostic delay in oral squamous cell carcinoma: the role of cognitive and psychological variables , 2013, International Journal of Oral Science.

[44]  K. Pantel,et al.  Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of Patients with Squamous Cell Carcinoma of the Oral Cavity , 2013, Clinical Cancer Research.

[45]  R. Aneja,et al.  Piper betel leaf extract: anticancer benefits and bio-guided fractionation to identify active principles for prostate cancer management. , 2013, Carcinogenesis.

[46]  J. Viola,et al.  NFAT1 C-Terminal Domains Are Necessary but Not Sufficient for Inducing Cell Death , 2012, PloS one.

[47]  Hefen Sun,et al.  Isocorydine Inhibits Cell Proliferation in Hepatocellular Carcinoma Cell Lines by Inducing G2/M Cell Cycle Arrest and Apoptosis , 2012, PloS one.

[48]  Natalie I. Tasman,et al.  A Cross-platform Toolkit for Mass Spectrometry and Proteomics , 2012, Nature Biotechnology.

[49]  Zheng Sun,et al.  Chemoprevention of oral cancer in animal models, and effect on leukoplakias in human patients with ZengShengPing, a mixture of medicinal herbs. , 2010, Oral oncology.

[50]  A. Rustgi,et al.  Cyclin D1 overexpression increases susceptibility to 4‐nitroquinoline‐1‐oxide‐induced dysplasia and neoplasia in murine squamous oral epithelium , 2009, Molecular carcinogenesis.

[51]  P. A. Harris,et al.  Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. , 2008, Journal of medicinal chemistry.

[52]  S. Giordano,et al.  From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. , 2008, Current medicinal chemistry.

[53]  Phuong Nguyen,et al.  A surface on the androgen receptor that allosterically regulates coactivator binding , 2007, Proceedings of the National Academy of Sciences.

[54]  G. Godoy,et al.  Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis. , 2007, International journal of surgical pathology.

[55]  L. Kowalski,et al.  Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. , 2007, Journal.

[56]  Andrew Potter,et al.  Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening. , 2006, Bioorganic & medicinal chemistry.

[57]  Artur Ferreira,et al.  Oral squamous cell carcinoma: review of prognostic and predictive factors. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[58]  W. Zong,et al.  Chemotherapeutic approaches for targeting cell death pathways. , 2006, The oncologist.

[59]  Jean-Louis Habib Jiwan,et al.  Key fragmentation patterns of aporphine alkaloids by electrospray ionization with multistage mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[60]  S. Tickoo,et al.  Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice , 2004, Clinical Cancer Research.

[61]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[62]  Sherry Sun,et al.  The Three-dimensional Structure of the Liver X Receptor β Reveals a Flexible Ligand-binding Pocket That Can Accommodate Fundamentally Different Ligands* , 2003, Journal of Biological Chemistry.

[63]  F. Hendler,et al.  Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. , 1994, Cancer research.

[64]  D. Ackermann,et al.  4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma , 1994, Head & neck.

[65]  I. Walker,et al.  The N2-guanine adduct but not the C8-guanine or N6-adenine adducts formed by 4-nitroquinoline 1-oxide blocks the 3'-5' exonuclease action of T4 DNA polymerase. , 1990, Biochemistry.

[66]  J. Coll,et al.  The Application of Vacuum Liquid Chromatography to the Separation of Terpene Mixtures , 1986 .

[67]  C. Carollo,et al.  Evaluation of the Effect of Brazilian Savanna (Cerrado) Seasons in Flavonoids and Alkaloids Accumulation: The Case of Duguetia furfuracea , 2021 .

[68]  Yong Yang,et al.  [Studies on the chemical components of Nelumbinis Plumula and the inhibitory activity on protein disulfide isomerase]. , 2017, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[69]  O. Issinger,et al.  Protein Kinase CK2 Cellular Function in Normal and Disease States , 2015, Advances in Biochemistry in Health and Disease.

[70]  S. Parasuraman,et al.  Toxicological screening , 2011, Journal of pharmacology & pharmacotherapeutics.